Genesco (NYSE:GCO – Get Free Report) was downgraded by stock analysts at StockNews.com from a “buy” rating to a “hold” rating in a note issued to investors on Thursday.
Genesco Stock Performance
Shares of NYSE:GCO traded up $1.71 during trading on Thursday, reaching $34.62. The company had a trading volume of 205,825 shares, compared to its average volume of 136,463. The firm has a market capitalization of $388.44 million, a price-to-earnings ratio of -494.50 and a beta of 2.41. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.53 and a quick ratio of 0.40. The stock’s fifty day moving average price is $28.57 and its 200 day moving average price is $27.68. Genesco has a fifty-two week low of $23.21 and a fifty-two week high of $37.89.
Genesco (NYSE:GCO – Get Free Report) last released its earnings results on Friday, September 6th. The company reported ($0.83) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($1.12) by $0.29. The business had revenue of $525.19 million for the quarter, compared to analyst estimates of $512.19 million. Genesco had a positive return on equity of 0.49% and a negative net margin of 0.03%. As a group, equities research analysts predict that Genesco will post 0.66 EPS for the current year.
Institutional Inflows and Outflows
Genesco Company Profile
Genesco Inc operates as a retailer and wholesaler of footwear, apparel, and accessories in the United States, Puerto Rico, Canada, the United Kingdom, and the Republic of Ireland. The company operates through four segments: Journeys Group, Schuh Group, Johnston & Murphy Group, and Genesco Brands.
Featured Articles
- Five stocks we like better than Genesco
- Financial Services Stocks Investing
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- What is a Special Dividend?
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- Following Congress Stock Trades
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for Genesco Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genesco and related companies with MarketBeat.com's FREE daily email newsletter.